Head-to-head · verified 2026-08-05
Amble Health vs. Big Easy Weight Loss: prices, fine print, and the honest verdict
Published pricing is incomplete on at least one side, so this matchup compares what can be verified — disclosure, terms, model — and says plainly where you'll need figures in writing.
- Amble Health
- Tirzepatide, all-in at 10 mg
- $300/mo
- Semaglutide, all-in
- Not offered
- Membership fee
- None
- Commitment
- unknown
- Cancellation
- not published
- Pharmacy
- not named
- First-year total (standing rate)
- $3,600
- Price evidence
- Third-party-reported
- Last verified
- 2026-08-05
- Big Easy Weight Loss
- Tirzepatide, all-in at 10 mg
- Offered — no published price
- Semaglutide, all-in
- Offered — no published price
- Membership fee
- None
- Commitment
- unknown
- Cancellation
- not published
- Pharmacy
- not named
- Price evidence
- No price published
- Last verified
- 2026-08-05
Tirzepatide pricing
Amble Health: $300 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Big Easy Weight Loss offers tirzepatide without a published price we could capture.
Transparency
Amble Health: Third-party-reported (verified 2026-08-05); dispensing pharmacy not publicly named. Big Easy Weight Loss: No price published (verified 2026-08-05); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.
Commitment & cancellation
Amble Health: unknown; not published. Big Easy Weight Loss: unknown; not published.
Amble Health: $300/mo verified all-in; Big Easy Weight Loss: no published price captured; verified floor $215 (NexLife); brand rails $349–$449. Basis: all-in monthly, 10 mg maintenance, capture-dated in the dataset.
Two ladders, side by side
Put both dose ladders on the same axis and the structures argue for themselves: Amble Health holds $300 on every rung (four-month titration: exactly $1,200). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.
The five normalizations, applied to this pair
1 · All-in, not advertised. Amble Health's ranked figure is $300, with no membership to add; Big Easy Weight Loss publishes no figure to normalize. 2 · Maintenance basis. Amble Health is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. Amble Health: standing $300, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Amble Health: third-party-reported, read 2026-08-05; Big Easy Weight Loss: no price published, read 2026-08-05. 5 · Pharmacy weighed. Amble Health names no pharmacy; Big Easy Weight Loss names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.
Fine print, itemized
Amble Health: no membership — the medication figure is the billed figure; not published; commitment: unknown. Big Easy Weight Loss: no membership — the medication figure is the billed figure; not published; commitment: unknown. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.
Transparency, audited
Amble Health carries third-party-reported pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Big Easy Weight Loss carries no price published pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.
Switching between them
Moving from Amble Health to Big Easy Weight Loss (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.
Refills, shipping, and the week-to-week reality
The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: Amble Health: shipping unknown; consultation unknown. Big Easy Weight Loss: shipping unknown; consultation unknown. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.
Who should pick which
Pick Amble Health if you want a price that survives titration. Pick Big Easy Weight Loss if its published terms happen to fit your state, format, or timing. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.
What verification would take
For Big Easy Weight Loss, ranking would require: any published price at all, on a page we can capture and date; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.
If neither one fits
The dataset's bench is deep; the closest verified third options to this matchup's price band are OrderlyMeds at $299 (flat, no membership); SkinnyRx at $299 (flat, no membership); Found at $289 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.
The brand benchmark both must beat
Neither program exists in a vacuum: FDA-approved Zepbound sits at $449/month at maintenance (LillyDirect or retail KwikPens, ~$350 on TrumpRx, ~$50 for newly eligible Medicare patients), and Wegovy at a flat $349. The cheaper of these two compounded options saves $1,788/year against the Zepbound benchmark — the number that has to justify accepting a not-FDA-reviewed product, per the full trade analysis. When a compounded quote drifts above ~$350, this benchmark starts winning the argument on its own.
The verdict
With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.
Quick answers
Which is cheaper, Amble Health or Big Easy Weight Loss?
Published pricing is incomplete on at least one side; the honest answer is to request current all-in figures in writing from both.
Can I switch between them?
Yes — patients move between telehealth programs routinely; you'll complete the new program's intake and prescriptions restart there. If you're also switching molecule or from compounded to brand, loop in the prescriber; our switching guide covers the clinical side.
Which is easier to cancel, Amble Health or Big Easy Weight Loss?
Amble Health: not published Big Easy Weight Loss: not published Cancel in writing either way; memberships cancel separately.
Is there a brand alternative to both?
Yes — Zepbound at $299–$449 via LillyDirect/retail (about $350 on TrumpRx; ~$50 for newly eligible Medicare patients) and Wegovy at a flat $349: FDA-approved products whose prices now sit close enough to make the comparison real.